These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18165235)

  • 1. Regulation of RON tyrosine kinase-mediated invasion of breast cancer cells.
    Thangasamy A; Rogge J; Ammanamanchi S
    J Biol Chem; 2008 Feb; 283(9):5335-43. PubMed ID: 18165235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells.
    Narasimhan M; Ammanamanchi S
    Cancer Res; 2008 Jul; 68(13):5185-92. PubMed ID: 18593918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells.
    Thangasamy A; Rogge J; Ammanamanchi S
    J Biol Chem; 2009 May; 284(21):14001-10. PubMed ID: 19307182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human receptor tyrosine kinase Axl gene--promoter characterization and regulation of constitutive expression by Sp1, Sp3 and CpG methylation.
    Mudduluru G; Allgayer H
    Biosci Rep; 2008 Jun; 28(3):161-76. PubMed ID: 18522535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and mutational status of RON in neoplastic lesions of the breast: analysis of MSP/RON signaling in ductal carcinoma in situ and invasive ductal carcinoma.
    Ren X; Daa T; Yada N; Kashima K; Fujitomi Y; Yokoyama S
    APMIS; 2012 May; 120(5):358-67. PubMed ID: 22515290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MSP-induced RON activation upregulates uPAR expression and cell invasiveness via MAPK, AP-1 and NF-κB signals in gastric cancer cells.
    Park JS; Park JH; Khoi PN; Joo YE; Jung YD
    Carcinogenesis; 2011 Feb; 32(2):175-81. PubMed ID: 21081472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel function of transcription factor Nrf2 as an inhibitor of RON tyrosine kinase receptor-mediated cancer cell invasion.
    Thangasamy A; Rogge J; Krishnegowda NK; Freeman JW; Ammanamanchi S
    J Biol Chem; 2011 Sep; 286(37):32115-22. PubMed ID: 21799005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MSP-RON axis stimulates cancer cell growth in models of triple negative breast cancer.
    Millar R; Kilbey A; Remak SJ; Severson TM; Dhayade S; Sandilands E; Foster K; Bryant DM; Blyth K; Coffelt SB
    Mol Oncol; 2020 Aug; 14(8):1868-1880. PubMed ID: 32484599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.
    Castro NE; Lange CA
    Breast Cancer Res; 2010; 12(4):R60. PubMed ID: 20687930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells.
    Feres KJ; Ischenko I; Hayman MJ
    Oncogene; 2009 Jan; 28(2):279-88. PubMed ID: 18836480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the binding specificity of human Recepteur d'Origine Nantais (RON) receptor tyrosine kinase to macrophage-stimulating protein.
    Chao KL; Gorlatova NV; Eisenstein E; Herzberg O
    J Biol Chem; 2014 Oct; 289(43):29948-60. PubMed ID: 25193665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.
    Wang MH; Wang D; Chen YQ
    Carcinogenesis; 2003 Aug; 24(8):1291-300. PubMed ID: 12807733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.
    Wang MH; Yao HP; Zhou YQ
    Acta Pharmacol Sin; 2006 Jun; 27(6):641-50. PubMed ID: 16723080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of the human translocator protein (18kDa) gene promoter in human breast cancer cell lines.
    Batarseh A; Barlow KD; Martinez-Arguelles DB; Papadopoulos V
    Biochim Biophys Acta; 2012 Jan; 1819(1):38-56. PubMed ID: 21958735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sp1 and Sp3 are involved in the full transcriptional activity of centromere protein H in human nasopharyngeal carcinoma cells.
    Zhao WF; Wang HB; Xie B; Hu LJ; Xu LH; Kuang BH; Li MZ; Zhang X
    FEBS J; 2012 Aug; 279(15):2714-26. PubMed ID: 22682030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide.
    Morrison AC; Wilson CB; Ray M; Correll PH
    J Immunol; 2004 Feb; 172(3):1825-32. PubMed ID: 14734766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage stimulating protein preserves blood brain barrier integrity after intracerebral hemorrhage through recepteur d'origine nantais dependent GAB1/Src/β-catenin pathway activation in a mouse model.
    Lu T; Wang Z; Prativa S; Xu Y; Wang T; Zhang Y; Yu L; Xu N; Tang J; You W; Chen G; Zhang JH
    J Neurochem; 2019 Jan; 148(1):114-126. PubMed ID: 30380151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RON, a tyrosine kinase receptor involved in tumor progression and metastasis.
    Camp ER; Liu W; Fan F; Yang A; Somcio R; Ellis LM
    Ann Surg Oncol; 2005 Apr; 12(4):273-81. PubMed ID: 15827676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GC-rich promoter elements maximally confers estrogen-induced transactivation of LRP16 gene through ERalpha/Sp1 interaction in MCF-7 cells.
    Han WD; Si YL; Zhao YL; Li Q; Wu ZQ; Hao HJ; Song HJ
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):47-56. PubMed ID: 18206366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma.
    Kim SA; Lee KH; Lee DH; Lee JK; Lim SC; Joo YE; Chung IJ; Noh MG; Yoon TM
    Int J Oncol; 2019 Aug; 55(2):513-526. PubMed ID: 31268163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.